| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/25/2012 | CN101850118B 加载于无机盐载体的脂溶性光敏剂的制备方法及其在制备光动力疗法药物中的应用 Preparation of inorganic carrier loaded on fat-soluble photosensitizer and its application in the manufacture of a medicament for photodynamic therapy |
| 04/25/2012 | CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free |
| 04/25/2012 | CN101816644B 一种紫杉醇与苯丙氨酸的组合物及其制备方法 One of paclitaxel and phenylalanine composition and preparation method |
| 04/25/2012 | CN101812097B 吲哚咔唑和双吲哚马来酰亚胺生物碱及其制备方法和应用 Indolocarbazole and bis-indole alkaloids maleimide and its preparation method and application |
| 04/25/2012 | CN101812063B α-萘磺酰胺基五元杂环类化合物及其抑瘤活性 α- naphthalene sulfonamide five yuan heterocyclic compounds and Antitumor Activity |
| 04/25/2012 | CN101747339B 1′-硫代氮杂靛玉红类化合物、用途及其制备方法 1'-aza Indirubin thiosulfate compounds, uses its preparation method |
| 04/25/2012 | CN101732724B 一种携载抗肿瘤药物的复合胶束及其制备方法 One kind of carrying antineoplastic complex micelles and its preparation method |
| 04/25/2012 | CN101703499B 两种化学抗肿瘤药物 Two chemical anticancer drugs |
| 04/25/2012 | CN101684163B 一种天麻多糖硫酸化衍生物及其制备方法和抗肿瘤用途 One kind of Gastrodia sulfated polysaccharide derivatives, preparation method and use of anti-tumor |
| 04/25/2012 | CN101675930B 用于治疗增生性疾病的药物组合物 For the treatment of proliferative diseases, pharmaceutical compositions |
| 04/25/2012 | CN101671656B 溶瘤Ⅰ型单纯疱疹病毒靶向和杀伤前列腺肿瘤细胞的方法 Oncolytic herpes simplex virus type Ⅰ targeting and killing of tumor cells of the prostate |
| 04/25/2012 | CN101619055B 氯化染料木素及其生物转化制备和应用方法 Preparation and application methods chlorinated genistein and biotransformation |
| 04/25/2012 | CN101602754B 一种二氢黄酮类衍生物及其制备方法和用途 One kind of flavanone derivatives and their preparation and use |
| 04/25/2012 | CN101602659B 用超临界CO<sub>2</sub>技术提取啤酒花渣中黄腐酚的方法 With supercritical CO <sub> 2 </ sub> Extraction xanthohumol in hops residue methods |
| 04/25/2012 | CN101597325B 一种纯化亮丙瑞林(Leuprorelin)的方法 A leuprolide (Leuprorelin) of purified |
| 04/25/2012 | CN101591315B Novel homoisoflavone compound and application thereof |
| 04/25/2012 | CN101568539B 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物 For imidazolinone amino pyrimidine compounds for treating cancer |
| 04/25/2012 | CN101548946B 姜黄素纳米脂质注射液、其制备方法及用途 Curcumin Nanoliposomal injection, their preparation and use |
| 04/25/2012 | CN101503457B 柱层析peg与干扰素类似物蛋白氮端定点偶联方法及其产物 Column chromatography peg interferon analog protein nitrogen end point coupling methods and their products |
| 04/25/2012 | CN101434649B 一种环七肽及其制备方法和应用 A cyclic heptapeptide and its preparation method and application |
| 04/25/2012 | CN101400680B 螺吲哚满酮衍生物 Spiro indolinone derivatives |
| 04/25/2012 | CN101397295B 作为组蛋白去乙酰化酶抑制剂的2-吲哚满酮衍生物、其制法和用途 As a histone deacetylase inhibitor 2-indolinone derivatives, their preparation and use |
| 04/25/2012 | CN101337000B 龙葵提取物、其制备方法及其药物用途 Solanum nigrum extract, their preparation and their pharmaceutical use |
| 04/25/2012 | CN101273773B 一种具有保健功能的中草药调味酱油 An herbal seasoning sauce with health care function |
| 04/24/2012 | US8163957 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease |
| 04/24/2012 | US8163904 Prepared by reacting free base with an acid in methanol under a nitrogen atmosphere; use in treating a disease which responds to an inhibition of protein kinase activity |
| 04/24/2012 | US8163805 Small molecule antagonists of Bcl-2 family proteins |
| 04/24/2012 | US8163762 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses |
| 04/24/2012 | US8163742 Di-amino-substituted heterocyclic compounds and methods of use |
| 04/24/2012 | US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 04/24/2012 | US8163719 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/24/2012 | US8163718 Nucleoside analogues containing phosphonate or phosphonamide groups |
| 04/24/2012 | US8163698 Dolastatin 15 derivatives |
| 04/24/2012 | US8163691 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 04/24/2012 | US8163536 Apparatus for use in the propagation of pluripotent cells |
| 04/24/2012 | US8163528 Nucleic acid molecules encoding thymidine kinase fusion proteins |
| 04/24/2012 | US8163494 Method for assessing metastatic properties of breast cancer |
| 04/24/2012 | US8163476 CUDR as biomarker for cancer progression and therapeutic response |
| 04/24/2012 | US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery |
| 04/24/2012 | US8163280 Antibodies to c-Met |
| 04/24/2012 | CA2680783C Heterocyclic compounds and their uses |
| 04/24/2012 | CA2645467C Pyridine derivative having anti-helicobacter pylori activity |
| 04/24/2012 | CA2542834C Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents |
| 04/24/2012 | CA2517544C Clostridial neurotoxins for treating uterine disorders |
| 04/24/2012 | CA2511479C Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
| 04/24/2012 | CA2499496C Synthesis and characterization of novel systems for guidance and vectorization of compounds having a therapeutic activity |
| 04/24/2012 | CA2493090C New derivatives of benzo[b]chromeno-naphthyridin-1-one and pyrano[2'3':7,8]quino[2,3-b]quinoxalin-7-one, method of preparing said derivatives and pharmaceutical compositions containing said derivatives |
| 04/24/2012 | CA2457011C Treatment of glial tumors with glutamate antagonists |
| 04/24/2012 | CA2452447C Antagonistic anti-htnfsf13b human antibodies |
| 04/24/2012 | CA2433807C Hydrophobic polyamine analogs and methods for their use |
| 04/24/2012 | CA2433582C Peptides having inhibiting activity on the production of nitric oxide |
| 04/24/2012 | CA2425599C Fumaric acid amides |
| 04/24/2012 | CA2414609C Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 04/19/2012 | WO2012051416A1 Pharmaceutical formulation for histone deacetylase inhibitors |
| 04/19/2012 | WO2012051407A2 Molecular containers and methods of making and using same |
| 04/19/2012 | WO2012051339A2 Methods and compositions for treating respiratory conditions using platelet enriched plasma |
| 04/19/2012 | WO2012051296A2 Purine-based triazoles |
| 04/19/2012 | WO2012051247A2 Egfr-based peptides |
| 04/19/2012 | WO2012051207A2 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS |
| 04/19/2012 | WO2012051204A2 Antimicrobial formulations that aid in wound healing |
| 04/19/2012 | WO2012051111A2 Human oncostatin m antibodies and methods of use |
| 04/19/2012 | WO2012051105A2 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 04/19/2012 | WO2012050985A1 Inhibitors of late sv40 factor (lsf) as cancer chemotherapeutics |
| 04/19/2012 | WO2012050921A2 Nd2 peptides and methods of treating neurological disease |
| 04/19/2012 | WO2012050735A1 Methods and dosage forms for the treatment of human cancers |
| 04/19/2012 | WO2012050532A1 Combination treatment of cancer |
| 04/19/2012 | WO2012050517A1 Imidazole substituted pyrimidine having a high gsk3 inhibiting potency as well as pan-kinase selectivity |
| 04/19/2012 | WO2012050500A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
| 04/19/2012 | WO2012050398A2 Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer |
| 04/19/2012 | WO2012050397A2 Pharmaceutical composition including herbal medicine extract for preventing or treating kidney cancer |
| 04/19/2012 | WO2012050396A2 Pharmaceutical composition including herbal medicine extract for preventing or treating liver cancer |
| 04/19/2012 | WO2012050393A2 Novel compound of a reverse-turn mimetic and a production method and use therefor |
| 04/19/2012 | WO2012050374A2 Immunotherapy for solid tumors |
| 04/19/2012 | WO2012050303A2 Pharmaceutical composition for cancer prevention and treatment containing the c12orf59 gene or protein as an active ingredient |
| 04/19/2012 | WO2012050264A1 Novel seleny-methyluracil compounds, radiosensitizer and pharmaceutical composition using them |
| 04/19/2012 | WO2012050263A1 Novel method of preparing endoxifen |
| 04/19/2012 | WO2012050184A1 Sustained-release pharmaceutical composition |
| 04/19/2012 | WO2012050154A1 Inhibitor of osteoclast formation containing anti-vdac antibody |
| 04/19/2012 | WO2012049658A1 Compound inhibiting tp53inp1 activity for the treatment of prostate cancer, and its use in screening and diagnostic methods |
| 04/19/2012 | WO2012049654A1 Bacterial ribonucleic acid cell wall compositions and methods of making and using them |
| 04/19/2012 | WO2012049647A1 Phosphatidylcholine in the treatment ophosphatidylcholinef tumours |
| 04/19/2012 | WO2012049636A1 Eif6 phosphorylation antagonists for use in medicine |
| 04/19/2012 | WO2012049440A1 Treatment of cancer/inhibition of metastasis |
| 04/19/2012 | WO2012049439A1 Treatment of cancer/inhibition of metastasis |
| 04/19/2012 | WO2012049431A2 Use of an anti-cd20 antibody for treating primary cerebral lymphoma |
| 04/19/2012 | WO2012049159A1 Composition for treating cancer by the controlled release of an active substance |
| 04/19/2012 | WO2012048775A1 Pyrrolidinones as metap2 inhibitors |
| 04/19/2012 | WO2012048667A1 Epidermal growth factor receptor variant lacking exon |
| 04/19/2012 | WO2012048653A1 Long-life interferon fusion protein and use thereof |
| 04/19/2012 | WO2012048522A1 Fructosylated puerarin, and preparation method therefor and use thereof |
| 04/19/2012 | WO2012048470A1 Small molecular ribonucleic acid complexes from mammals |
| 04/19/2012 | WO2012048446A1 New use of chemical ingredients in cynomorium as phytoestrogen |
| 04/19/2012 | WO2012048411A1 Plk-4 inhibitors and method of treating cancer with same |
| 04/19/2012 | WO2012032524A9 Near infrared fluorescent particles and uses thereof |
| 04/19/2012 | WO2012024519A3 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 04/19/2012 | WO2012015937A9 Parp1 targeted therapy |
| 04/19/2012 | WO2012014046A3 Supramolecular aggregates as drug carriers on cell expressing receptors for branched neurotensin |
| 04/19/2012 | WO2012009288A9 Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer |
| 04/19/2012 | WO2012009262A3 Diclofenac salt of tramadol |
| 04/19/2012 | WO2011163533A4 One step removal of selected molecules from body fluid and tissue |